|
SV Veerramani
|
IDMA has been conducting several training programmes and workshops for raising the quality and GMP compliance over the years. Now, we will do it with much more vigour in order to strengthen the confidence of the international community on the safety and efficacy of pharmaceutical products produced in India. Besides the recent India Pharma Regulatory & Compliance Summit 2014 conducted by us in coordination with UL India, we are planning to have several such initiatives jointly with UL India.
We are also planning to have a seminar on ‘Managing Risk for Quality Compliance’ with the support of our Quality Management & Technical Committee in various centres of India. IDMA has also instituted Quality Excellence Awards in order to encourage and celebrate quality. A team of experts from the industry visits participating pharma plants and evaluate them on several parameters of quality systems, documentation, best practices for GMP adherence, etc.
Every year, we have a Pharmaceutical Analysts Convention (PAC) to discuss on the current trends with respect to Regulatory Compliance and Quality adherence. Besides, we are also planning to work with our CDSCO, India, US FDA and UK MHRA on workshops with respect to cGMP. We also have a Regulatory Affairs Committee which constantly guides our members on the current regulatory requirements.